Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
J Surg Oncol
    April 2024
  1. DIAS AR, Pereira MA, Ramos MFKP, de Oliveira RJ, et al
    Robotic versus laparoscopic gastrectomy for gastric cancer: A Western propensity score matched analysis.
    J Surg Oncol. 2024 Apr 17. doi: 10.1002/jso.27651.
    >> Share

    March 2024
  2. NAQVI A, Matias N, Al-Khaffaf B
    Reporting of core outcomes in gastric cancer surgery trials over the past 25 years (systematic review).
    J Surg Oncol. 2024 Mar 6. doi: 10.1002/jso.27613.
    >> Share

  3. KIM JY, Love M, Woo Y, Campos B, et al
    Pilot study of a telehealth intervention for personalized self-management for eating symptoms after gastroesophageal cancer surgery.
    J Surg Oncol. 2024;129:728-733.
    >> Share

    February 2024
  4. LILLEY EJ, Lu P, Robinson K, Griffith H, et al
    High symptom burden in patients undergoing gastrectomy for cancer.
    J Surg Oncol. 2024;129:228-232.
    >> Share

    January 2024
  5. HONDO N, Yamamoto Y, Nakabe T, Otsubo T, et al
    Short-term outcomes of laparoscopic and robotic distal gastrectomy for gastric cancer: Real-world evidence from a large-scale inpatient database in Japan.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27575.
    >> Share

  6. VAN DER WIELEN N, Brenkman H, Seesing M, Daams F, et al
    Minimally invasive versus open gastrectomy for gastric cancer. A pooled analysis of two European randomized controlled trials.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27578.
    >> Share

  7. SESTITO M, Pratt H, Schmidt C, Thomay A, et al
    Recent advances for treatment of upper gastrointestinal malignancy.
    J Surg Oncol. 2024;129:48-62.
    >> Share

    December 2023
  8. CASPERS IA, Slagter AE, Lind P, Sikorska K, et al
    The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial.
    J Surg Oncol. 2023 Dec 10. doi: 10.1002/jso.27554.
    >> Share

  9. KARALIS JD, Ju MR, Feig R, Estrella R, et al
    Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascites.
    J Surg Oncol. 2023 Dec 8. doi: 10.1002/jso.27556.
    >> Share

    November 2023
  10. JANCZEWSKI LM, Logan CD, Vitello DJ, Buchheit JT, et al
    Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27521.
    >> Share

    October 2023
  11. MAVANI PT, Ajay PS, Goyal S, Shah MM, et al
    Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 17. doi: 10.1002/jso.27483.
    >> Share

  12. LOUAFI MO, Lahnaoui O, Benkabbou A, Majbar MA, et al
    Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 16. doi: 10.1002/jso.27452.
    >> Share

    June 2023
  13. JANCZEWSKI LM, Shah D, Wells A, Bentrem DJ, et al
    The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
    J Surg Oncol. 2023;127:1116-1124.
    >> Share

    April 2023
  14. AJAY PS, Sok CP, Goyal S, Switchenko JM, et al
    Impact of nodal status in determining multimodal treatment strategies in non-cardia gastric cancer.
    J Surg Oncol. 2023 Apr 28. doi: 10.1002/jso.27297.
    >> Share

  15. AJAY PS, NeMoyer R, Goyal S, Switchenko JM, et al
    Does non-metastatic gastric cancer of the cardia warrant a different treatment strategy?
    J Surg Oncol. 2023 Apr 10. doi: 10.1002/jso.27276.
    >> Share

    February 2023
  16. AYLOOR SESHADRI R, Soman AC, Aggrawal A, Karnawat A, et al
    Conditional survival in patients treated for gastric cancer with a curative intent.
    J Surg Oncol. 2023 Feb 3. doi: 10.1002/jso.27209.
    >> Share

    January 2023
  17. MARKOPOULOS GS, Vartholomatos G, Alexiou GAlpha, Tatsis V, et al
    Resection margin status evaluation in gastric cancer surgery by intraoperative flow cytometry.
    J Surg Oncol. 2023 Jan 4. doi: 10.1002/jso.27187.
    >> Share

    December 2022
  18. WATANABE A, McKendry GJ, Yip L, Donnellan F, et al
    Risk of lymph node metastasis in early gastric cancer for a Western population.
    J Surg Oncol. 2022 Dec 30. doi: 10.1002/jso.27192.
    >> Share

  19. YANG XY, Zhu K, Hu Q
    The order of surgery and chemotherapy matters: Multimodality therapy and stage-specific differences in survival in gastric cancer.
    J Surg Oncol. 2022 Dec 7. doi: 10.1002/jso.27158.
    >> Share

  20. STILLMAN MD, Kusche N, Toledano S, Hilfrank KJ, et al
    Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.
    J Surg Oncol. 2022;126:1413-1422.
    >> Share

  21. WU L, Xing Z, Huang M, Yu H, et al
    Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients.
    J Surg Oncol. 2022;126:1403-1412.
    >> Share

    October 2022
  22. RAMOS-SANTILLAN V, Friedmann P, Eskander M, Chuy J, et al
    The order of surgery and chemotherapy matters: Multimodality therapy and stage-specific differences in survival in gastric cancer.
    J Surg Oncol. 2022 Oct 4. doi: 10.1002/jso.27110.
    >> Share

  23. COIT DG, Strong VE
    Fifty years of progress in gastric cancer.
    J Surg Oncol. 2022;126:865-871.
    >> Share

    September 2022
  24. WATANABE A, Adamson H, Lim H, McFadden AF, et al
    Intraoperative frozen section analysis of margin status as a quality indicator in gastric cancer surgery.
    J Surg Oncol. 2022 Sep 30. doi: 10.1002/jso.27107.
    >> Share

  25. VAN KOOTEN RT, Bahadoer RR, Ter Buurkes de Vries B, Wouters MWJM, et al
    Conventional regression analysis and machine learning in prediction of anastomotic leakage and pulmonary complications after esophagogastric cancer surgery.
    J Surg Oncol. 2022;126:490-501.
    >> Share

  26. LEDER MACEK AJ, Wang A, Turgeon MK, Lee RM, et al
    Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis.
    J Surg Oncol. 2022;126:649-657.
    >> Share

    August 2022
  27. STILLMAN MD, Yoon SS
    Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes.
    J Surg Oncol. 2022;126:279-291.
    >> Share

    July 2022
  28. RUGGE M, Genta RM
    Gastric cancer prevention: Merging future hopes, with present clinical practice.
    J Surg Oncol. 2022 Jul 19. doi: 10.1002/jso.26997.
    >> Share

  29. DA COSTA WL, Tran Cao HS, Gu X, Massarweh NN, et al
    Understanding the association between clinical staging accuracy, treatment response, and survival among gastric cancer patients through Bayesian analysis.
    J Surg Oncol. 2022 Jul 12. doi: 10.1002/jso.27016.
    >> Share

  30. RIBEIRO HSC, Menezes JN, da Costa WL Jr, F de Jesus VH, et al
    PD-L1 expression in gastric and gastroesophageal junction cancer patients treated with perioperative chemotherapy.
    J Surg Oncol. 2022;126:150-160.
    >> Share

  31. DA SILVA JPA, Martins MR, Dos Santos RL, da Silva LM, et al
    Evaluation of platelet activation marker expression and its correlation with tumorigenesis and tumor progression in patients with gastric cancer.
    J Surg Oncol. 2022;126:125-131.
    >> Share

  32. DIAS AR, Pereira MA, Ramos MFKP, Barchi LC, et al
    Gastrectomy for elderly gastric cancer patients: A propensity score-matching analysis.
    J Surg Oncol. 2022;126:108-115.
    >> Share

  33. DIAS AR, Pereira MA, Ramos MFKP, Ribeiro U Jr, et al
    Preoperative chemotherapy is a better strategy than upfront surgery in cT4 gastric cancer.
    J Surg Oncol. 2022;126:132-138.
    >> Share

  34. DIAS AR, Pereira MA, Ramos MFKP, Ribeiro U Jr, et al
    Multivisceral resection compared to standard gastrectomy for gastric adenocarcinoma: A propensity score-matching analysis.
    J Surg Oncol. 2022;126:99-107.
    >> Share

  35. PEREIRA MA, Dias AR, Ramos MFKP, Cardili L, et al
    Gastric cancer with microsatellite instability displays increased thymidylate synthase expression.
    J Surg Oncol. 2022;126:116-124.
    >> Share

  36. LIMA CAC, da Silva LM, Dos Santos RL, Silva JPA, et al
    Unbalanced expression of sICOS and sPD-1 correlates with tumor progression in gastric cancer.
    J Surg Oncol. 2022;126:144-149.
    >> Share

  37. LIMA CAC, Martins MR, Dos Santos RL, da Silva LM, et al
    High soluble OX40 levels correlate with metastatic gastric cancer.
    J Surg Oncol. 2022;126:139-143.
    >> Share

  38. SOUADKA A, Essangri H, Elazzaoui F, Majbar MA, et al
    Staging laparoscopy in locally advanced gastric cancer: Beware the poorly differentiated histological subtype.
    J Surg Oncol. 2022 Jul 1. doi: 10.1002/jso.26966.
    >> Share

    June 2022
  39. SHAH D, Bentrem D
    Environmental and genetic risk factors for gastric cancer.
    J Surg Oncol. 2022;125:1096-1103.
    >> Share

  40. MESCI A, Wong RK
    Current and future strategies for radiation therapy in gastric cancer.
    J Surg Oncol. 2022;125:1161-1175.
    >> Share

  41. SCHMIDT CR
    Innovations defining the future of gastric cancer-Introduction.
    J Surg Oncol. 2022;125:1077-1078.
    >> Share

  42. ENGEL D, Saric S, Minnella E, Carli F, et al
    Strategies for optimal perioperative outcomes in gastric cancer.
    J Surg Oncol. 2022;125:1135-1141.
    >> Share

  43. SCHMIDT CR
    Innovations defining the future of gastric cancer: Summary.
    J Surg Oncol. 2022;125:1183.
    >> Share

  44. ORTIGAO R, Libanio D, Dinis-Ribeiro M
    The future of endoscopic resection for early gastric cancer.
    J Surg Oncol. 2022;125:1110-1122.
    >> Share

  45. KHAN H, Johnston FM
    Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease.
    J Surg Oncol. 2022;125:1176-1182.
    >> Share

  46. THAM E, Sestito M, Markovich B, Garland-Kledzik M, et al
    Current and future imaging modalities in gastric cancer.
    J Surg Oncol. 2022;125:1123-1134.
    >> Share

  47. CHOI S, Hyung WJ
    Modern surgical therapy for gastric cancer-Robotics and beyond.
    J Surg Oncol. 2022;125:1142-1150.
    >> Share

  48. XIA JY, Aadam AA
    Advances in screening and detection of gastric cancer.
    J Surg Oncol. 2022;125:1104-1109.
    >> Share

  49. IVEY A, Pratt H, Boone BA
    Molecular pathogenesis and emerging targets of gastric adenocarcinoma.
    J Surg Oncol. 2022;125:1079-1095.
    >> Share

  50. CORSO G
    Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management.
    J Surg Oncol. 2022;125:1326-1331.
    >> Share

  51. BRACALE U, Peltrini R, Corcione F
    "Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score matched study"-Authors' reply.
    J Surg Oncol. 2022;125:1338-1339.
    >> Share

    April 2022
  52. KASLOW SR, Ma Z, Hani L, Prendergast K, et al
    Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer.
    J Surg Oncol. 2022 Apr 26. doi: 10.1002/jso.26895.
    >> Share

    March 2022
  53. SPOLVERATO G, Paro A, Capelli G, Dalmacy D, et al
    Surgical treatment of gastric adenocarcinoma: Are we achieving textbook oncologic outcomes for our patients?
    J Surg Oncol. 2022;125:621-630.
    >> Share

  54. CANN C, Ciombor KK
    Systemic therapy for gastric cancer: Perioperative strategies and beyond.
    J Surg Oncol. 2022 Mar 1. doi: 10.1002/jso.26834.
    >> Share

    January 2022
  55. KOBAYASHI H, Honda M, Kawamura H, Takiguchi K, et al
    Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination.
    J Surg Oncol. 2022 Jan 5. doi: 10.1002/jso.26770.
    >> Share

  56. BADGWELL B
    Regional therapy trials in peritoneal metastases: The path to standardization of care for gastric cancer.
    J Surg Oncol. 2022;125:64-68.
    >> Share

    December 2021
  57. VAN WINSEN M, McSorley ST, McLeod R, MacDonald A, et al
    Postoperative C-reactive protein concentrations to predict infective complications following gastrectomy for cancer.
    J Surg Oncol. 2021;124:1060-1069.
    >> Share

  58. LI Z, Wang Y, Ying X, Zhang L, et al
    Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
    J Surg Oncol. 2021;124:1356-1364.
    >> Share

  59. WANG Y, Liu Z, Shan F, Ying X, et al
    Short-term outcomes after totally laparoscopic total gastrectomy with esophagojejunostomy constructed by pi-shaped method versus overlap method.
    J Surg Oncol. 2021;124:1329-1337.
    >> Share

  60. BRACALE U, Corcione F, Pignata G, Andreuccetti J, et al
    Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score-matched study.
    J Surg Oncol. 2021;124:1338-1346.
    >> Share

  61. KRONENFELD JP, Collier AL, Turgeon MK, Ju M, et al
    Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.
    J Surg Oncol. 2021;124:1317-1328.
    >> Share

    November 2021
  62. HU Q, Chen J, Sun Y
    Comment on "Staged laparoscopic management of locally advanced gastric cancer with outlet obstruction".
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26560.
    >> Share

  63. HU Q, Sun J, Zhu KF
    Postoperative C-reactive protein concentrations to predict infective complications of gastric cancer.
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26649.
    >> Share

  64. HU Q, Sun J
    Perioperative-enhanced recovery protocol in patients undergoing open gastrectomy for gastric cancer.
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26630.
    >> Share

    September 2021
  65. KIM J, Han SH, Kim HI
    Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
    J Surg Oncol. 2021 Sep 7. doi: 10.1002/jso.26668.
    >> Share

    August 2021
  66. WEST MA, Baker WC, Rahman S, Munro A, et al
    Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection.
    J Surg Oncol. 2021 Aug 31. doi: 10.1002/jso.26652.
    >> Share

    July 2021
  67. KARALIS JD, Ju MR, Mansour JC, Polanco PM, et al
    The presentation of Hispanic gastric cancer patients varies by location of patient ancestry.
    J Surg Oncol. 2021 Jul 15. doi: 10.1002/jso.26609.
    >> Share

  68. PEREIRA MA, de Castria TB, Ramos MFKP, Dias AR, et al
    Cytotoxic T-lymphocyte-associated protein 4 in gastric cancer: Prognosis and association with PD-L1 expression.
    J Surg Oncol. 2021 Jul 13. doi: 10.1002/jso.26604.
    >> Share

  69. BLUMENTHALER AN, Robinson KA, Kruse BC, Munder K, et al
    Implementation of a perioperative-enhanced recovery protocol in patients undergoing open gastrectomy for gastric cancer.
    J Surg Oncol. 2021 Jul 6. doi: 10.1002/jso.26591.
    >> Share

  70. APTE SS, Radonjic A, Wong B, Dingley B, et al
    Preoperative imaging of gastric GISTs underestimates pathologic tumor size: A retrospective, single institution analysis.
    J Surg Oncol. 2021;124:49-58.
    >> Share

  71. DU J, Xue H, Zhao L, Zhang Z, et al
    Handover method: Simple, classic and harmonized intracorporeal closure of stapled duodenal stump during laparoscopic gastrectomy.
    J Surg Oncol. 2021;124:41-48.
    >> Share

    June 2021
  72. TURGEON MK, Lee RM, Keilson JM, Ju MR, et al
    Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?
    J Surg Oncol. 2021 Jun 1. doi: 10.1002/jso.26554.
    >> Share

  73. RAO T S, Raju KVVN, Patnaik SC, Reddy P, et al
    Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in India.
    J Surg Oncol. 2021;123:1547-1557.
    >> Share

    May 2021
  74. ITAI Y, Ueda Y, Etoh T, Shirasaka Y, et al
    Clinical significance of sarcoid-like reaction in lymph nodes of gastric cancer patients.
    J Surg Oncol. 2021 May 18. doi: 10.1002/jso.26525.
    >> Share

  75. HONG J, Wang YP, Wang J, Hua LC, et al
    The safety and feasibility of intra-corporeal gastroduodenostomy using a self-pulling and latter transected method (Delta SPLT) in totally laparoscopic distal gastrectomy.
    J Surg Oncol. 2021;123 Suppl 1:S25-S29.
    >> Share

  76. CAI Z, Ma J, Li S, Fingerhut A, et al
    Impact of microsatellite status on negative lymph node count and prognostic relevance after curative gastrectomy.
    J Surg Oncol. 2021;123 Suppl 1:S15-S24.
    >> Share

    April 2021
  77. LIN JX, Huang YQ, Wang ZK, Xie JW, et al
    Prognostic importance of dynamic changes in systemic inflammatory markers for patients with gastric cancer.
    J Surg Oncol. 2021 Apr 29. doi: 10.1002/jso.26498.
    >> Share

  78. ZHANG LY, Ma JJ, Zang L, Hong HJ, et al
    Staged laparoscopic management of locally advanced gastric cancer with outlet obstruction.
    J Surg Oncol. 2021 Apr 5. doi: 10.1002/jso.26342.
    >> Share

    March 2021
  79. LIU J, Li H, Zhou P, Cai T, et al
    Reevaluation of lymphovascular invasion in gastric cancer using endothelial markers D2-40 and EVG: Enhanced detection, better predictor of lymph node metastasis and biological aggressiveness.
    J Surg Oncol. 2021 Mar 26. doi: 10.1002/jso.26468.
    >> Share

  80. RAJABNEJAD A, Vaida F, Valasek M, Razzaque S, et al
    Predictors and significance of histologic response to neoadjuvant therapy for gastric cancer.
    J Surg Oncol. 2021 Mar 18. doi: 10.1002/jso.26458.
    >> Share

  81. PORTUONDO JI, Tran Cao HS, da Costa WL, Sada YH, et al
    Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer.
    J Surg Oncol. 2021 Mar 15. doi: 10.1002/jso.26460.
    >> Share

  82. WU T, Wang CH, Wang W, Liu LL, et al
    Association of preoperative and postoperative CA72-4 with gastric cancer outcome.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26446.
    >> Share

  83. WEI Q, Xu Q, Yuan X, Li JJ, et al
    Immunological impact of chemotherapy on the tumor microenvironment in gastric cancer.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26449.
    >> Share

  84. KOEMANS WJ, van der Kaaij RT, Wassenaar ECE, Boerma D, et al
    Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial.
    J Surg Oncol. 2021;123:904-910.
    >> Share

  85. BLUMENTHALER AN, Newhook TE, Ikoma N, Estrella JS, et al
    Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival.
    J Surg Oncol. 2021;123:911-922.
    >> Share

    January 2021
  86. LOMBARDI PM, Mazzola M, Achilli P, Aquilano MC, et al
    Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
    J Surg Oncol. 2021 Jan 26. doi: 10.1002/jso.26391.
    >> Share

    December 2020
  87. PANDURO-CORREA V, Cubas WS, Herrera-Matta JJ, Maguina JL, et al
    Survival and adequate preoperative staging in patients undergoing gastric cancer surgery at a Peruvian Police Hospital.
    J Surg Oncol. 2020 Dec 1. doi: 10.1002/jso.26315.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016